• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆汁纤连蛋白在胆管癌诊断中的价值。

The value of biliary fibronectin for diagnosis of cholangiocarcinoma.

作者信息

Chen Chiung-Yu, Lin Xi-Zhang, Tsao Hui-Chen, Shiesh Shu-Chu

机构信息

Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

出版信息

Hepatogastroenterology. 2003 Jul-Aug;50(52):924-7.

PMID:12845951
Abstract

BACKGROUND/AIMS: The fibronectin in various body fluids was reported to be useful in the differential diagnosis of benign and malignant diseases. We conducted this study to assess the diagnostic value of biliary fibronectin.

METHODOLOGY

Bile was collected from patients with gallstones (n = 62), benign biliary stricture (n = 5) and cholangiocarcinoma (n = 28). All patients with gallstones were complicated with cholangitis. The absolute biliary level of fibronectin was determined by an immunoenzymatric assay and divided by the biliary concentration of bile acids to calculate the relative concentration.

RESULTS

The relative concentration of biliary fibronectin was significantly different among the patients with benign biliary obstruction, gallstone and cholangiocarcinoma (7.1 +/- 14.3 vs. 350.5 +/- 1535.4 vs. 180592.6 +/- 917236.2, p < 0.05). With a cut-off value of 40 ng/mumol, its sensitivity for diagnosing cholangiocarcinoma was 0.57, and specificity, 0.79.

CONCLUSIONS

As bile may be concentrated or diluted to a various extent after biliary obstruction, the relative concentration of biliary fibronectin is more useful than the absolute concentration in differentiating the causes of biliary obstruction. In addition to the presence of biliary cancer, biliary fibronectin was also increased in response to biliary inflammation, which limits its use as a tumor marker of cholangiocarcinoma.

摘要

背景/目的:据报道,各种体液中的纤连蛋白有助于良恶性疾病的鉴别诊断。我们开展本研究以评估胆汁纤连蛋白的诊断价值。

方法

收集胆结石患者(n = 62)、良性胆管狭窄患者(n = 5)和胆管癌患者(n = 28)的胆汁。所有胆结石患者均合并胆管炎。采用免疫酶法测定胆汁中纤连蛋白的绝对水平,并除以胆汁酸的胆汁浓度以计算相对浓度。

结果

良性胆管梗阻、胆结石和胆管癌患者胆汁纤连蛋白的相对浓度存在显著差异(7.1±14.3 vs. 350.5±1535.4 vs. 180592.6±917236.2,p < 0.05)。以40 ng/μmol为临界值,其诊断胆管癌的敏感性为0.57,特异性为0.79。

结论

由于胆管梗阻后胆汁可能会在不同程度上浓缩或稀释,胆汁纤连蛋白的相对浓度在鉴别胆管梗阻原因方面比绝对浓度更有用。除了存在胆管癌外,胆汁纤连蛋白也会因胆管炎症而升高,这限制了其作为胆管癌肿瘤标志物的应用。

相似文献

1
The value of biliary fibronectin for diagnosis of cholangiocarcinoma.胆汁纤连蛋白在胆管癌诊断中的价值。
Hepatogastroenterology. 2003 Jul-Aug;50(52):924-7.
2
The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.胆汁中CA 125、CA 19-9和CEA在胆管癌诊断中的评估——采样时间和肝内胆管结石的影响
Hepatogastroenterology. 2002 May-Jun;49(45):616-20.
3
The value of biliary amylase and Hepatocarcinoma-Intestine-Pancreas/Pancreatitis-associated Protein I (HIP/PAP-I) in diagnosing biliary malignancies.胆汁淀粉酶和肝癌-肠-胰腺/胰腺炎相关蛋白I(HIP/PAP-I)在诊断胆道恶性肿瘤中的价值。
Clin Biochem. 2005 Jun;38(6):520-5. doi: 10.1016/j.clinbiochem.2005.01.012.
4
Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.胆汁癌胚抗原水平是胆管癌的一个标志物。
Am J Surg. 1996 Jan;171(1):147-52; discussion 152-3. doi: 10.1016/S0002-9610(99)80090-7.
5
Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.严重胆管狭窄患者血清胰蛋白酶原-2对胆管癌的检测效能增强
J Hepatol. 2007 Nov;47(5):677-83. doi: 10.1016/j.jhep.2007.05.017. Epub 2007 Jun 27.
6
Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.胆管癌的蛋白质组学分析:表面增强激光解吸电离飞行时间质谱在恶性胆管狭窄中的诊断潜力
Hepatology. 2006 Sep;44(3):658-66. doi: 10.1002/hep.21294.
7
Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.原发性硬化性胆管炎患者与非原发性硬化性胆管炎患者胆汁磁共振波谱检测胆管癌
Acta Radiol. 2008 Oct;49(8):855-62. doi: 10.1080/02841850802220092.
8
[Fibronectin in human bile--a new parameter for diagnosis of malignant bile duct processes?--A pilot study].
Z Gastroenterol. 1994 Feb;32(2):87-90.
9
Fibronectin in human bile fluid for diagnosis of malignant biliary diseases.人胆汁中的纤连蛋白用于恶性胆道疾病的诊断。
Hepatology. 1996 Mar;23(3):423-8. doi: 10.1002/hep.510230305.
10
The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.CA 19-9在无原发性硬化性胆管炎患者胆管癌诊断中的应用
Am J Gastroenterol. 2000 Jan;95(1):204-7. doi: 10.1111/j.1572-0241.2000.01685.x.

引用本文的文献

1
Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.利用蛋白质组学方法鉴别胆管癌与良性胆道疾病的新型血清生物标志物
Dis Markers. 2015;2015:105358. doi: 10.1155/2015/105358. Epub 2015 Apr 28.
2
Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures.胆汁生物标志物辅助先进内镜成像技术诊断不明原因胆管狭窄
World J Gastrointest Endosc. 2015 Apr 16;7(4):308-17. doi: 10.4253/wjge.v7.i4.308.
3
The value of molecular biomarkers in biliary tract cancer in the era of targeted therapy.
靶向治疗时代胆道癌分子生物标志物的价值
J Clin Exp Hepatol. 2011 Jun;1(1):2-5. doi: 10.1016/S0973-6883(11)60118-7. Epub 2011 Aug 26.
4
Novel endoscopic approaches in the diagnosis and management of biliary strictures.胆道狭窄诊断与治疗中的新型内镜技术
F1000Prime Rep. 2013 Sep 2;5:38. doi: 10.12703/P5-38.
5
Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.胆管癌衍生成纤维细胞的基因表达谱分析显示与肿瘤进展相关的改变,并表明骨桥蛋白作为一个不良预后标志物。
Mol Cancer. 2010 Jan 24;9:13. doi: 10.1186/1476-4598-9-13.